Literature DB >> 25921136

Stromal modulation and its role in the diagnosis of papillary patterned thyroid lesions.

Sahar Aly Daoud1, Reham Shehab El Nemr Esmail, Amal Ahmed Hareedy, Abdullah Khalil.   

Abstract

The papillary patterned lesion of thyroid may be challenging with many diagnostic pitfalls. Tumor stroma plays an important part in the determination of the tumor phenotype. CD34 is thought to be involved in the modulation of cell adhesion and signal transduction as CD34(+) fibrocytes are potent antigen-presenting cells. Smooth muscle actin (SMA) positivity could be diagnostic for fibroblast activation during tumorigenesis. We aimed to examine the expression of CD34 and alphaSMA in the stroma of papillary thyroid hyperplasia, papillary thyroid carcinoma and papillary tumors of uncertain malignant potential in order to elucidate their possible differential distribution and roles. A total number of 54 cases with papillary thyroid lesions were studied by routine HandE staining, CD34 and ASMA immunostaining. ASMA was not expressed in benign papillary hyperplastic lesions while it was expressed in papillary carcinoma, indicating that tumors have modulated stroma. Although the stroma was not well developed in papillary lesions with equivocal features of uncertain potentiality, CD34 was notable in such cases with higher incidence in malignant cases. So ASMA as well as CD34 could predict neoplastic behavior, pointing to the importance of the stromal role. Differences between groups suggest that the presence of CD34 + stromal cells is an early event in carcinogensis and is associated with neoplasia, however ASMA+ cells are more likely to be associated with malignant behavior and metastatic potential adding additional tools to the light microscopic picture helping in diagnosis of problematic cases with HandE.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25921136     DOI: 10.7314/apjcp.2015.16.8.3307

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  5 in total

1.  Inflammatory Components of the Thyroid Cancer Microenvironment: An Avenue for Identification of Novel Biomarkers.

Authors:  Tara Jarboe; Neha Y Tuli; Sanjukta Chakraborty; Rachana R Maniyar; Nicole DeSouza; Augustine Moscatello; Jan Geliebter; Raj K Tiwari
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  Clinicopathological significance of cancer-associated fibroblasts in papillary thyroid carcinoma: a predictive marker of cervical lymph node metastasis.

Authors:  Jae-Gu Cho; Hyung Kwon Byeon; Kyung Ho Oh; Seung-Kuk Baek; Soon-Young Kwon; Kwang-Yoon Jung; Jeong-Soo Woo
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-07-17       Impact factor: 2.503

3.  Nine Genes Mediate the Therapeutic Effects of Iodine-131 Radiotherapy in Thyroid Carcinoma Patients.

Authors:  Han Shuwen; Yang Xi; Da Miao; Xu Jiamin; Zhuang Jing; Gao Weili
Journal:  Dis Markers       Date:  2020-06-16       Impact factor: 3.434

4.  Age-related long-term response in rat thyroid tissue and plasma after internal low dose exposure to 131I.

Authors:  Malin Larsson; Nils-Petter Rudqvist; Johan Spetz; Toshima Z Parris; Britta Langen; Khalil Helou; Eva Forssell-Aronsson
Journal:  Sci Rep       Date:  2022-02-08       Impact factor: 4.996

5.  Cancer Associated Fibroblasts and Senescent Thyroid Cells in the Invasive Front of Thyroid Carcinoma.

Authors:  Emanuela Minna; Silvia Brich; Katia Todoerti; Silvana Pilotti; Paola Collini; Elisa Bonaldi; Paola Romeo; Loris De Cecco; Matteo Dugo; Federica Perrone; Adele Busico; Andrea Vingiani; Ilaria Bersani; Andrea Anichini; Roberta Mortarini; Antonino Neri; Giancarlo Pruneri; Angela Greco; Maria Grazia Borrello
Journal:  Cancers (Basel)       Date:  2020-01-01       Impact factor: 6.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.